☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Tryp Therapeutics
Tryp Therapeutics Reports the First Patient Dosing with TRP-8802 in P-IIa Clinical Trial for the Treatment of Fibromyalgia
January 5, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.